{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:19:29Z","timestamp":1791285569484,"version":"4.1.0"},"reference-count":51,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2009,4,28]],"date-time":"2009-04-28T00:00:00Z","timestamp":1240876800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Liver International"],"published-print":{"date-parts":[[2009,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:bold>Aims:<\/jats:bold>\n                    The aim of this study was to determine whether serum levels of adipokines, including the ratio of serum adiponectin to leptin (A\/L) levels could predict the severity of liver injury in patients with non\u2010alcoholic fatty liver disease (NAFLD).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Patients and methods:<\/jats:bold>\n                    Fifty\u2010seven patients with biopsy\u2010proven non\u2010alcoholic steatohepatitis (NASH) (mean age 51\u00b112, sex ratio 1), 17 with simple steatosis (mean age 47\u00b112, sex ratio 1.4) and 10 controls without steatosis (mean age 51\u00b111, sex ratio 4) were investigated. In all subjects, serum concentrations of triglycerides, ultrasensitive C reactive protein, leptin, adiponectin, soluble tumour necrosis factor receptor 1, interleukin (IL)\u20106 and Homeostasis Model Assessment Method (HOMA) were measured. Hepatic expression of adiponectin and its two receptors was assessed by quantitative reverse transcriptase polymerase chain reaction.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    Body mass index (BMI) and HOMA were correlated positively with leptin levels (\n                    <jats:italic>r<\/jats:italic>\n                    =0.44 and 0.28 respectively) and negatively with the A\/L ratio (\n                    <jats:italic>r<\/jats:italic>\n                    =0.51 and 0.41 respectively). Independent parameters associated with NASH vs steatosis were HOMA&gt;3 [odds ratio (OR)=6.9] and A\/L ratio &lt;1.4 10\n                    <jats:sup>3<\/jats:sup>\n                    (OR=5.2). The combination of HOMA with A\/L ratio showed an area under the receiver operating characteristic curve of 0.82 for distinguishing between NASH and steatosis. Extensive portal fibrosis was present in 17 (23%) patients with NAFLD. Three independent parameters were associated with fibrosis: age (OR=1.1), BMI (OR=1.3) and high IL\u20106 levels (OR=1.6). The hepatic expression of adiponectin receptor 2 was significantly higher in patients with NASH compared with controls and was related with necroinflammatory injury.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions:<\/jats:bold>\n                    This study shows that in patients with NAFLD, the combination of HOMA with A\/L ratio may be a useful non\u2010invasive approach to appreciate the severity of liver damage.\n                  <\/jats:p>","DOI":"10.1111\/j.1478-3231.2009.02022.x","type":"journal-article","created":{"date-parts":[[2009,4,28]],"date-time":"2009-04-28T06:17:37Z","timestamp":1240899457000},"page":"1431-1438","source":"Crossref","is-referenced-by-count":116,"title":["Serum adipokine levels predictive of liver injury in non\u2010alcoholic fatty liver disease"],"prefix":"10.1111","volume":"29","author":[{"given":"Maud","family":"Lemoine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vlad","family":"Ratziu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minji","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustapha","family":"Maachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Wendum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Paye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Philippe","family":"Bastard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raoul","family":"Poupon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Housset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Capeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Serfaty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,9,3]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra011775"},{"key":"e_1_2_6_3_2","first-page":"1844","article-title":"Nonalcoholic fatty liver disease","volume":"50","author":"Marchesini G","year":"2001","journal-title":"a feature of the metabolic syndrome"},{"key":"e_1_2_6_4_2","first-page":"1413","article-title":"Nonalcoholic fatty liver disease","volume":"116","author":"Matteoni CA","year":"1999","journal-title":"a spectrum of clinical and pathological severity"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.33324"},{"key":"e_1_2_6_6_2","first-page":"134","article-title":"Expanding the natural history of nonalcoholic steatohepatitis","volume":"123","author":"Bugianesi E","year":"2002","journal-title":"from cryptogenic cirrhosis to hepatocellular carcinoma"},{"key":"e_1_2_6_7_2","first-page":"S99","article-title":"Nonalcoholic fatty liver disease","volume":"43","author":"Farrell GC","year":"2006","journal-title":"from steatosis to cirrhosis"},{"key":"e_1_2_6_8_2","first-page":"987","article-title":"Insulin resistance","volume":"42","author":"Bugianesi E","year":"2005","journal-title":"a metabolic pathway to chronic liver disease"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.2174\/1566524053766022"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1997.8193"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.2001.5134"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200317797"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1210\/er.2005-0005"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1530\/eje.1.01960"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07450.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.08767.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.00297.x"},{"key":"e_1_2_6_18_2","first-page":"1175","article-title":"Adipokines in NASH","volume":"42","author":"Musso G","year":"2005","journal-title":"postprandial lipid metabolism as a link between adiponectin and liver disease"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mcg.0000152747.79773.2f"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.8.2085"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2004.02151.x"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v11.i12.1737"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200602000-00010"},{"key":"e_1_2_6_24_2","first-page":"46","article-title":"Beyond insulin resistance in NASH","volume":"40","author":"Hui JM","year":"2004","journal-title":"TNF-alpha or adiponectin?"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mcg.0000152747.79773.2f"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-2240"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2005.01209.x"},{"key":"e_1_2_6_28_2","first-page":"2684","article-title":"Leptin","volume":"48","author":"Kotani K","year":"2005","journal-title":"adiponectin ratio as an atherosclerotic index in patients with type 2 diabetes: relationship of the index to carotid intima-media thickness"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.10.2488"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2004.09.006"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200307040-00011"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-5491.2002.00745.x"},{"key":"e_1_2_6_33_2","first-page":"2467","article-title":"Nonalcoholic steatohepatitis","volume":"94","author":"Brunt EM","year":"1999","journal-title":"a proposal for grading and staging the histological lesions"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1006\/meth.2001.1262"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.03297.x"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1999.0255"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hepres.2005.09.024"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2006.07.039"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50161"},{"key":"e_1_2_6_40_2","first-page":"1202","article-title":"Nonalcoholic steatohepatitis","volume":"37","author":"Neuschwander\u2010Tetri BA","year":"2003","journal-title":"summary of an AASLD Single Topic Conference"},{"key":"e_1_2_6_41_2","first-page":"91","article-title":"Nonalcoholic fatty liver disease","volume":"121","author":"Dixon JB","year":"2001","journal-title":"predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(00)70364-7"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.11.043"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20400"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21087"},{"key":"e_1_2_6_46_2","first-page":"547","article-title":"Increased plasma interleukin\u20106 concentrations in alcoholic hepatitis","volume":"119","author":"Hill DB","year":"1992","journal-title":"J Lab Clin Med"},{"key":"e_1_2_6_47_2","first-page":"413","article-title":"Cytokines and NASH","volume":"38","author":"Kugelmas M","year":"2003","journal-title":"a pilot study of the effects of lifestyle modification and vitamin E"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.037010"},{"key":"e_1_2_6_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.05.030"},{"key":"e_1_2_6_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2005.06.004"},{"key":"e_1_2_6_51_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature01705"},{"key":"e_1_2_6_52_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M402367200"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1478-3231.2009.02022.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1478-3231.2009.02022.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T17:23:04Z","timestamp":1695921784000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1478-3231.2009.02022.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,3]]},"references-count":51,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["10.1111\/j.1478-3231.2009.02022.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1478-3231.2009.02022.x","archive":["Portico"],"relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,3]]}}}